Overview
Hypromellose, or hydroxypropyl methylcellulose (HPMC) , is a semisynthetic, inert, and viscoelastic polymer that forms a colloid solution when dissolved in water. It acts as a thickening agent, coating polymer, bioadhesive, solubility enhancer in solid dispersions, and binder in the process of granulation and in modified release formulations . It is a commonly used as a delivery component in oral pharmaceutical products that provides the release of a drug in a controlled fashion, effectively increasing the duration of release of a drug to prolong its therapeutic effects . Hypromellose is also found in eye drops as a lubricant .
Indication
Used as an ophthalmic protectant and lubricant, in artificial tears, and as a diagnostic aid (contact lens procedures; gonioscopy).
Associated Conditions
- Dry Eyes
- Ocular Discomfort
- Ocular Irritation
Research Report
A Comprehensive Monograph on Hypromellose (DB11075): Physicochemical Properties, Pharmaceutical Applications, and Safety Profile
1.0 Executive Summary
Hypromellose, also known by its chemical name hydroxypropyl methylcellulose (HPMC), is a semisynthetic, inert, viscoelastic polymer derived from cellulose. It stands as a cornerstone of modern pharmaceutical science due to its remarkable versatility, functioning as both a primary therapeutic agent in ophthalmic formulations and an indispensable excipient in a vast array of oral and topical drug delivery systems.[1] This monograph provides a comprehensive analysis of Hypromellose, integrating its physicochemical characteristics, pharmacological mechanisms, pharmacokinetic profile, clinical applications, and safety data. The fundamental utility of Hypromellose is rooted in a predictable structure-function paradigm, where its molecular properties—specifically the degree of chemical substitution and polymer chain length—can be precisely modulated to control macroscopic behaviors such as viscosity, hydration rate, and thermal gelation. This tunability allows for the engineering of specific performance outcomes, from providing gentle, long-lasting lubrication for the ocular surface to orchestrating the complex, zero-order release of active pharmaceutical ingredients from once-daily oral tablets.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/07/03 | Not Applicable | Not yet recruiting | Center for Sight Las Vegas | ||
2025/03/20 | Phase 4 | Recruiting | |||
2025/01/08 | Phase 4 | Recruiting | |||
2024/04/23 | Phase 1 | Not yet recruiting | |||
2024/01/24 | Phase 4 | Completed | Chang Gung Memorial Hospital | ||
2024/01/23 | Phase 4 | Completed | Scripps Poway Eyecare and Optometry | ||
2024/01/03 | Phase 2 | Completed | |||
2023/01/30 | Phase 4 | Completed | |||
2022/10/26 | Phase 4 | Completed | Tauber Eye Center | ||
2021/04/30 | Not Applicable | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
LOSTEAR EYE DROPS 0.3% W/V | N/A | N/A | N/A | 7/6/2016 | |
GENTEAL EYE GEL | N/A | alcon hong kong ltd | N/A | N/A | 2/16/2004 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
MediHerb Gotu Kola Complex (Export Only) | 389071 | Medicine | A | 5/25/2022 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
ARTELAC LUBRICANT EYE DROPS | bausch & lomb inc | 02251523 | Solution - Ophthalmic | 0.32 % | 3/25/2005 |
VISINE CONTACT LENS | johnson & johnson inc | 02229483 | Drops - Ophthalmic | 0.2 % | 8/24/1998 |
LUBRICANT EYE DROPS | kc pharmaceuticals inc | 02455579 | Solution - Ophthalmic | 0.2 % / W/V | N/A |
DRY EYE TEARS | juno otc inc | 02389886 | Solution - Ophthalmic | 0.2 % / W/V | 2/12/2014 |
ALCON TEARS 1% | Alcon Canada Inc | 00000817 | Solution - Ophthalmic | 1 % / W/V | 12/31/1970 |
TEARS NATURALE | Alcon Canada Inc | 00390291 | Solution - Ophthalmic | 0.3 % | 12/31/1977 |
TEARS NATURALE FORTE | Alcon Canada Inc | 02246397 | Solution - Ophthalmic | 0.3 % | 1/2/2003 |
VISINE FOR DRY EYE EYE REVIVAL | johnson & johnson inc | 02436132 | Drops - Ophthalmic | 0.2 % / W/V | 5/19/2016 |
ARTIFICIAL TEARS | juno otc inc | 02354535 | Solution - Ophthalmic | 0.2 % / W/V | 4/19/2011 |
CORNEO HYPROMELLOSE | orimed pharma inc | 02439921 | Solution - Ophthalmic | 0.3 % | 9/16/2015 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
HIPROMELOSA LESVI 3,2 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS | Laboratorios Lesvi Sl | 78526 | COLIRIO EN SOLUCIÓN EN ENVASE UNIDOSIS | Sin Receta | Not Commercialized |
ACUOLENS 3 mg/ml + 5,5 mg/ml COLIRIO EN SOLUCION EN ENVASE UNIDOSIS | Alcon Healthcare S.A. | 62630 | COLIRIO EN SOLUCIÓN | Sin Receta | Commercialized |
HIPROMELOSA STADA 3,2 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS | Laboratorio Stada S.L. | 78527 | COLIRIO EN SOLUCIÓN EN ENVASE UNIDOSIS | Sin Receta | Commercialized |
ARTIFIC 3,20 MG/ML COLIRIO EN SOLUCION | 14328 | COLIRIO EN SOLUCIÓN | Sin Receta | Not Commercialized | |
ARTIFIC 3,20 mg/ml COLIRIO EN SOLUCION EN ENVASE UNIDOSIS | Bausch & Lomb S.A. | 65809 | COLIRIO EN SOLUCIÓN | Sin Receta | Commercialized |
DACROLUX 3MG/ML +1MG/ML COLIRIO EN SOLUCIÓN | Reva Health Europe S.L. | 58742 | COLIRIO EN SOLUCIÓN | Sin Receta | Not Commercialized |
ARTIFIC 3,20 mg/ml COLIRIO EN SOLUCION EN ENVASE UNIDOSIS | 3400934035890 | COLIRIO EN SOLUCIÓN | Sin Receta | Commercialized | |
ARTIFIC 3,20 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS | 14329 | COLIRIO EN SOLUCIÓN EN ENVASE UNIDOSIS | Sin Receta | Not Commercialized | |
HIPROMELOSA QUALIGEN 3,2 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSIS | Neuraxpharm Spain S.L. | 78532 | COLIRIO EN SOLUCIÓN EN ENVASE UNIDOSIS | Sin Receta | Not Commercialized |
ARTIFIC 3,20 mg/ml COLIRIO EN SOLUCION | Bausch & Lomb S.A. | 65810 | COLIRIO EN SOLUCIÓN | Sin Receta | Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.